Categories Retail

Starbucks is hoping to mollify investors with summer-special beverages

Things have not been going so great with Starbucks (SBUX) lately. Its shares are currently trading at a yearly low of $50.70 on concerns over its unstable future, which were spurred by last week’s store closures and weak sales outlook. In an attempt to appease investors and customers alike, the coffee chain announced that it would launch two new limited-edition cold form tea lemonades in the US and Canada.

The tea lemonades – Summer Sunrise and Summer Sunset – will have the herbal tea flavor with tropical pineapple infusion and velvety cold foam. These two beverages add on to the Mango Dragonfruit Refreshers beverage, which was launched on Tuesday.

Related: Starbucks shares plunge on weak sales outlook and store closure

Starbucks is hoping to mollify investors with summer-special beverages

After a tumultuous year, Starbucks is hoping to get back to its feet with the introduction of the summer special beverages. Only a week ago, the coffee chain had announced its decision to shutter 150 out of its 8,000 stores in the next financial year. This is a three-fold increase in store closures, as it generally shuts only around 50 stores annually.

Also, the company provided a weaker-than-expected sales guidance, whereby Starbucks predicts a 1% rise in same-store sales. In contrast, the company is taking a hole in its own pocket by announcing a 20% dividend hike and its intention to return about $25 billion in the capital.

Starbucks’ shares have been trading between $50.70 and $61.94 for the past 52 weeks.

Most Popular

Microsoft (MSFT) reports higher revenue and profit for Q3 2024

Microsoft Corp. (NASDAQ: MSFT) on Thursday said its third-quarter 2024 earnings increased year-over-year, reflecting strong performance by the tech giant’s main operating segments. Third-quarter revenues came in at $61.86 billion,

GOOG, GOOGL Earnings: All you need to know about Alphabet’s Q1 2024 earnings results

Alphabet Inc. (NASDAQ: GOOG, GOOGL) reported its first quarter 2024 earnings results today. Revenues increased 15% year-over-year to $80.5 billion. Revenue growth was 16% in constant currency. Net income was

MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided by an increase in revenues. First-quarter worldwide sales

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top